Lymphoma,%20Large-Cell,%20Anaplastic
Showing 9976 - 10000 of >10,000
Recurrent Urinary Tract Infection Trial in Worldwide (Methenamine Hippurate 1000 MG)
Enrolling by invitation
- Recurrent Urinary Tract Infection
- Methenamine Hippurate 1000 MG
-
Utrecht, Netherlands
- +3 more
Sep 27, 2021
From Micro- to Macro-vessels : Water, Salt, Heart and Kidneys
Recruiting
- Hypertension
- Explorations are planned as part of the one-day hospitalization
-
Paris, IDF, FranceCentre Interdisciplinaire de Thérapeutique et d'Education APHP-
Dec 20, 2021
Celiac Disease Trial in Boston (Gluten Powder)
Recruiting
- Celiac Disease
- Gluten Powder
-
Boston, MassachusettsCeliac Research Centre Mass General Hospital
Jul 1, 2022
MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)
Not yet recruiting
- MEN1 Gene Mutation
- Leflunomide 20 mg
-
Basel, SwitzerlandUnispital Basel
Nov 1, 2022
Characterization of the Melanoma-Specific Immune Response
Recruiting
- Melanoma
-
Sacramento, CaliforniaUniversity of California, Davis Department of Dermatology
Nov 3, 2021
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022
HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple
Recruiting
- HER2-negative Early Breast Cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
-
Beijing, ChinaPeking University People's Hospital
Mar 27, 2022
Either EML4-ALK Gene Rearrangements or T790M EGFR Mutation in
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
-
Hollywood, Florida
- +1 more
Sep 29, 2021
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))
Completed
- Acute Lymphoblastic Leukemia (ALL)
- Marqibo® (vincristine sulfate liposomes injection)
-
Los Angeles, California
- +32 more
Feb 8, 2021
Study (EPIPHANY)
Recruiting
- Chemotherapy-induced Peripheral Neuropathy
-
Tucson, Arizona
- +11 more
Feb 28, 2022
CIBMTR Research Database
Recruiting
- Autologous Stem Cell Transplantation
- +6 more
-
Minneapolis, Minnesota
- +1 more
Jan 20, 2023
Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los
Recruiting
- Clear Cell Papillary Renal Neoplasm
- +10 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021
Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in
Completed
- Blasts 10 Percent or More of Bone Marrow Nucleated Cells
- +8 more
- Cladribine
- +13 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 11, 2021
Primary Ovarian Insufficiency Trial in Zhengzhou (Cell therapy)
Active, not recruiting
- Primary Ovarian Insufficiency
- Cell therapy
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Aug 4, 2021
Alcohol Use Disorder Trial in New Haven (CBT4CBT in the Black Church)
Recruiting
- Alcohol Use Disorder
- CBT4CBT in the Black Church
-
New Haven, Connecticut
- +1 more
Nov 1, 2021
Type I ANTi-Interferon Antibodies in COVID-19 Acute Respiratory
Completed
- Acute Respiratory Failure
-
Créteil, FranceAssistance Publique Hôpitaux de Paris - CHU HENRI MONDOR
Nov 8, 2021
Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)
Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (Anlotinib Plus Irinotecan, Irinotecan)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Anlotinib Plus Irinotecan
- Irinotecan
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Aug 30, 2021
Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland
Not yet recruiting
- Allogeneic Stem Cell Transplant Candidate
- +4 more
- Cellular therapy product
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022
Perioperative Covert Stroke and Postoperative Cognitive
Recruiting
- Anesthesia
- +2 more
-
Beijing, ChinaBeijing TianTan Hospital
Sep 12, 2021
Hemodynamic Characteristics of Patients With SARS-CoV-2
Completed
- Coronavirus
- +7 more
- Transpulmonary thermodilution
- Echocardiography
-
Paris, Val-de-Marne, FranceBicetre Hospital
Sep 13, 2021
Absence, School Phobia, Truancy; Socialized Trial in Norway (The Back 2 School program for problematic school absenteeism)
Recruiting
- Absence
- +3 more
- The Back 2 School program for problematic school absenteeism
-
Bergen, Norway
- +3 more
Dec 7, 2022
Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)
Active, not recruiting
- Non Small Cell Lung Cancer
- Necitumumab
- +2 more
-
Chandler, Arizona
- +181 more
Feb 4, 2022
Sleep Apnea Trial in Bruxelles (Movesense MD)
Not yet recruiting
- Sleep Apnea
- Movesense MD
-
Bruxelles, BelgiumErasme hospital
Sep 1, 2023
Advanced Solid Tumor, Aggressive Non-Hodgkin Lymphoma, Recurrent Solid Tumor Trial in Chicago (other, biological, drug)
Unknown status
- Advanced Solid Neoplasm
- +5 more
- Laboratory Biomarker Analysis
- +3 more
-
Chicago, IllinoisNorthwestern University
Oct 27, 2020